Chemomab Therapeutics (CMMB) Cash & Current Investments (2011 - 2026)
Chemomab Therapeutics (CMMB) posted Cash & Current Investments of $6.69 million for Q2 2026, down 29.7% from $9.51 million a year earlier and down 16.9% from the prior quarter.
Powered by 
Analysis
Chemomab Therapeutics (CMMB) Cash & Current Investments (2011 - 2026) Analysis & Trends
At the end of FY2025, Chemomab Therapeutics' Cash & Current Investments came in at $10.37 million, down 27.3% from FY2024.
- Annual Cash & Current Investments has declined for three consecutive years, with a five-year compound annual growth rate of -2.3% (FY2020 to FY2025).
- In prior years, Chemomab Therapeutics' Cash & Current Investments was $14.27 million in FY2024 (-40.8%), $24.09 million in FY2023 (-42.1%), $41.62 million in FY2022 (+173.0%) and $15.24 million in FY2021 (+30.6%).
- The Q2 2026 figure stands as the lowest quarterly Cash & Current Investments since Q4 2017.
- On a year-over-year basis, Cash & Current Investments has declined in each of the last 11 quarters, with an average decline of 29.8% over the last eight quarters.
- The strongest year-over-year quarter for Cash & Current Investments in the past five years was Q3 2021, with growth of 457.7%; the weakest was Q2 2022, with a decline of 78.1%.
- According to Business Quant data, Cash & Current Investments for the three prior quarters was $8.04 million (Q1 2026), $10.37 million (Q4 2025) and $10.06 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Chemomab Therapeutics | 7.41 Mn | -27.74 Mn | - | 6.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.69 Mn |
| Mar 31, 2026 | 8.04 Mn |
| Dec 31, 2025 | 10.37 Mn |
| Sep 30, 2025 | 10.06 Mn |
| Jun 30, 2025 | 9.37 Mn |
| Mar 31, 2025 | 10.56 Mn |
| Dec 31, 2024 | 14.27 Mn |
| Sep 30, 2024 | 19.38 Mn |
| Jun 30, 2024 | 12.73 Mn |
| Mar 31, 2024 | 15.88 Mn |
| Dec 31, 2023 | 19.78 Mn |
| Sep 30, 2023 | 21.37 Mn |
| Jun 30, 2023 | 26.59 Mn |
| Mar 31, 2023 | 20.77 Mn |
| Dec 31, 2022 | 39.89 Mn |
| Sep 30, 2022 | 10.74 Mn |
| Jun 30, 2022 | 9.88 Mn |
| Mar 31, 2022 | 13.83 Mn |
| Dec 31, 2021 | 15.19 Mn |
| Sep 30, 2021 | 37.74 Mn |
API Access
Chemomab Therapeutics Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=CMMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "CMMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=CMMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();